InvestorsHub Logo
Followers 19
Posts 901
Boards Moderated 0
Alias Born 05/31/2013

Re: None

Wednesday, 11/08/2017 9:55:27 AM

Wednesday, November 08, 2017 9:55:27 AM

Post# of 48316
I think an important take away from the article is feursteinPoints out that insight has a $23 billion market value, and that half of that value– – Meaning over $11 billion of that market value – – is attributed to the still unapproved epacadostat. He’s basically saying that ImmunoPulse /OncoSec should be valued similarly if not more so since it is further along in its development.